0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Immunoglobulin G4-related disease (IgG4-RD) and systemic sclerosis (SSc) are rare autoimmune diseases characterized by the presence of CD4+ cytotoxic T cells in the blood as well as inflammation and fibrosis in various organs, but they have no established etiologies. Similar to other autoimmune diseases, the gut microbiome might encode disease-triggering or disease-sustaining factors.

          Methods

          The gut microbiomes from IgG4-RD and SSc patients as well as healthy individuals with no recent antibiotic treatment were studied by metagenomic sequencing of stool DNA. De novo assembly-based taxonomic and functional characterization, followed by association and accessory gene set enrichment analysis, were applied to describe microbiome changes associated with both diseases.

          Results

          Microbiomes of IgG4-RD and SSc patients distinctly separated from those of healthy controls: numerous opportunistic pathogenic Clostridium and typically oral Streptococcus species were significantly overabundant, while Alistipes, Bacteroides, and butyrate-producing species were depleted in the two diseases compared to healthy controls. Accessory gene content analysis in these species revealed an enrichment of Th17-activating Eggerthella lenta strains in IgG4-RD and SSc and a preferential colonization of a homocysteine-producing strain of Clostridium bolteae in SSc. Overabundance of the classical mevalonate pathway, hydroxyproline dehydratase, and fibronectin-binding protein in disease microbiomes reflects potential functional differences in host immune recognition and extracellular matrix utilization associated with fibrosis. Strikingly, the majority of species that were differentially abundant in IgG4-RD and SSc compared to controls showed the same directionality in both diseases. Compared with multiple sclerosis and rheumatoid arthritis, the gut microbiomes of IgG4-RD and SSc showed similar signatures; in contrast, the most differentially abundant taxa were not the facultative anaerobes consistently identified in inflammatory bowel diseases, suggesting the microbial signatures of IgG4-RD and SSc do not result from mucosal inflammation and decreased anaerobism.

          Conclusions

          These results provide an initial characterization of gut microbiome ecology in fibrosis-prone IgG4-RD and SSc and reveal microbial functions that offer insights into the pathophysiology of these rare diseases.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s13073-021-00853-7.

          Related collections

          Most cited references65

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Fast and accurate short read alignment with Burrows–Wheeler transform

          Motivation: The enormous amount of short reads generated by the new DNA sequencing technologies call for the development of fast and accurate read alignment programs. A first generation of hash table-based methods has been developed, including MAQ, which is accurate, feature rich and fast enough to align short reads from a single individual. However, MAQ does not support gapped alignment for single-end reads, which makes it unsuitable for alignment of longer reads where indels may occur frequently. The speed of MAQ is also a concern when the alignment is scaled up to the resequencing of hundreds of individuals. Results: We implemented Burrows-Wheeler Alignment tool (BWA), a new read alignment package that is based on backward search with Burrows–Wheeler Transform (BWT), to efficiently align short sequencing reads against a large reference sequence such as the human genome, allowing mismatches and gaps. BWA supports both base space reads, e.g. from Illumina sequencing machines, and color space reads from AB SOLiD machines. Evaluations on both simulated and real data suggest that BWA is ∼10–20× faster than MAQ, while achieving similar accuracy. In addition, BWA outputs alignment in the new standard SAM (Sequence Alignment/Map) format. Variant calling and other downstream analyses after the alignment can be achieved with the open source SAMtools software package. Availability: http://maq.sourceforge.net Contact: rd@sanger.ac.uk
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Prodigal: prokaryotic gene recognition and translation initiation site identification

            Background The quality of automated gene prediction in microbial organisms has improved steadily over the past decade, but there is still room for improvement. Increasing the number of correct identifications, both of genes and of the translation initiation sites for each gene, and reducing the overall number of false positives, are all desirable goals. Results With our years of experience in manually curating genomes for the Joint Genome Institute, we developed a new gene prediction algorithm called Prodigal (PROkaryotic DYnamic programming Gene-finding ALgorithm). With Prodigal, we focused specifically on the three goals of improved gene structure prediction, improved translation initiation site recognition, and reduced false positives. We compared the results of Prodigal to existing gene-finding methods to demonstrate that it met each of these objectives. Conclusion We built a fast, lightweight, open source gene prediction program called Prodigal http://compbio.ornl.gov/prodigal/. Prodigal achieved good results compared to existing methods, and we believe it will be a valuable asset to automated microbial annotation pipelines.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              CD-HIT: accelerated for clustering the next-generation sequencing data

              Summary: CD-HIT is a widely used program for clustering biological sequences to reduce sequence redundancy and improve the performance of other sequence analyses. In response to the rapid increase in the amount of sequencing data produced by the next-generation sequencing technologies, we have developed a new CD-HIT program accelerated with a novel parallelization strategy and some other techniques to allow efficient clustering of such datasets. Our tests demonstrated very good speedup derived from the parallelization for up to ∼24 cores and a quasi-linear speedup for up to ∼8 cores. The enhanced CD-HIT is capable of handling very large datasets in much shorter time than previous versions. Availability: http://cd-hit.org. Contact: liwz@sdsc.edu Supplementary information: Supplementary data are available at Bioinformatics online.
                Bookmark

                Author and article information

                Contributors
                xavier@molbio.mgh.harvard.edu
                Journal
                Genome Med
                Genome Med
                Genome Medicine
                BioMed Central (London )
                1756-994X
                28 February 2021
                28 February 2021
                2021
                : 13
                : 35
                Affiliations
                [1 ]GRID grid.66859.34, Broad Institute of MIT and Harvard, ; Cambridge, MA USA
                [2 ]GRID grid.5373.2, ISNI 0000000108389418, Department of Computer Science, , Aalto University, ; 02150 Espoo, Finland
                [3 ]GRID grid.418424.f, ISNI 0000 0004 0439 2056, Novartis Institute for Biomedical Research, ; Cambridge, MA USA
                [4 ]GRID grid.32224.35, ISNI 0000 0004 0386 9924, Division of Rheumatology, Allergy, and Immunology, , Massachusetts General Hospital, ; Boston, MA USA
                [5 ]GRID grid.32224.35, ISNI 0000 0004 0386 9924, Clinical Epidemiology Program and Rheumatology Unit, , Massachusetts General Hospital and Harvard Medical School, ; Boston, MA USA
                [6 ]GRID grid.461656.6, ISNI 0000 0004 0489 3491, Ragon Institute of MGH, MIT and Harvard, ; Cambridge, MA USA
                [7 ]GRID grid.32224.35, ISNI 0000 0004 0386 9924, Division of Gastroenterology, , Massachusetts General Hospital and Harvard Medical School, ; Boston, MA USA
                [8 ]GRID grid.32224.35, ISNI 0000 0004 0386 9924, Center for Cancer Risk Assessment, , Massachusetts General Hospital and Harvard Medical School, ; Boston, MA USA
                [9 ]GRID grid.214458.e, ISNI 0000000086837370, University of Michigan Scleroderma Program, ; Ann Arbor, MI USA
                [10 ]GRID grid.32224.35, ISNI 0000 0004 0386 9924, Center for Computational and Integrative Biology, , Massachusetts General Hospital and Harvard Medical School, ; Boston, MA USA
                [11 ]GRID grid.32224.35, ISNI 0000 0004 0386 9924, Department of Molecular Biology, , Massachusetts General Hospital and Harvard Medical School, ; Boston, MA USA
                [12 ]GRID grid.116068.8, ISNI 0000 0001 2341 2786, Center for Microbiome Informatics and Therapeutics, MIT, ; Cambridge, MA USA
                Author information
                http://orcid.org/0000-0002-5630-5167
                Article
                853
                10.1186/s13073-021-00853-7
                7919092
                33648559
                eb60d721-f284-4389-9705-983699d05721
                © The Author(s) 2021

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 24 July 2020
                : 11 February 2021
                Funding
                Funded by: National Institutes of Health (US)
                Award ID: U19 AI110495
                Funded by: FundRef http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: UM1 AI144295
                Award ID: UM1-AI-110557
                Award ID: K24 AR063120
                Categories
                Research
                Custom metadata
                © The Author(s) 2021

                Molecular medicine
                gut microbiome,igg4-rd,systemic sclerosis,autoimmunity
                Molecular medicine
                gut microbiome, igg4-rd, systemic sclerosis, autoimmunity

                Comments

                Comment on this article